远程慢性病患者监测的经济评价：系统评价。

Economic Evaluations of Remote Patient Monitoring for Chronic Disease: A Systematic Review.

机构信息

Centre for Online Health, The University of Queensland, Brisbane, Australia; Centre for Health Services Research, The University of Queensland, Brisbane, Australia.

出版信息

Value Health. 2022 Jun;25(6):897-913. doi: 10.1016/j.jval.2021.12.001. Epub 2022 Jan 11.

DOI:10.1016/j.jval.2021.12.001

PMID:35667780

Abstract

OBJECTIVES

This study aimed to systematically review and summarize economic evaluations of noninvasive remote patient monitoring (RPM) for chronic diseases compared with usual care.

METHODS

A systematic literature search identified economic evaluations of RPM for chronic diseases, compared with usual care. Searches of PubMed, Embase, CINAHL, and EconLit using keyword synonyms for RPM and economics identified articles published from up until September 2021. Title, abstract, and full-text reviews were conducted. Data extraction of study characteristics and health economic findings was performed. Article reporting quality was assessed using the Consolidated Health Economic Evaluation Reporting Standards checklist.

RESULTS

This review demonstrated that the cost-effectiveness of RPM was dependent on clinical context, capital investment, organizational processes, and willingness to pay in each specific setting. RPM was found to be highly cost-effective for hypertension and may be cost-effective for heart failure and chronic obstructive pulmonary disease. There were few studies that investigated RPM for diabetes or other chronic diseases. Studies were of high reporting quality, with an average Consolidated Health Economic Evaluation Reporting Standards score of 81%. Of the final 34 included studies, most were conducted from the healthcare system perspective. Eighteen studies used cost-utility analysis, 4 used cost-effectiveness analysis, 2 combined cost-utility analysis and a cost-effectiveness analysis, 1 used cost-consequence analysis, 1 used cost-benefit analysis, and 8 used cost-minimization analysis.

CONCLUSIONS

RPM was highly cost-effective for hypertension and may achieve greater long-term cost savings from the prevention of high-cost health events. For chronic obstructive pulmonary disease and heart failure, cost-effectiveness findings differed according to disease severity and there was limited economic evidence for diabetes interventions.

摘要

目的

本研究旨在系统地回顾和总结非侵入性远程患者监测（RPM）与常规护理相比用于慢性病的经济评价。

方法

系统检索PubMed、Embase、CINAHL 和 EconLit 中使用 RPM 和经济学关键字同义词的经济评价，以确定截至 2021 年 9 月发表的文章。进行标题、摘要和全文审查。对研究特征和健康经济结果进行数据提取。使用合并健康经济评估报告标准清单评估文章报告质量。

结果

本综述表明，RPM 的成本效益取决于每个特定环境中的临床背景、资本投资、组织流程和支付意愿。RPM 被发现对高血压具有高度成本效益，并且对心力衰竭和慢性阻塞性肺疾病可能具有成本效益。几乎没有研究调查 RPM 用于糖尿病或其他慢性病。研究报告质量较高，平均合并健康经济评估报告标准得分为 81%。在最终纳入的 34 项研究中，大多数是从医疗保健系统的角度进行的。18 项研究使用成本效用分析，4 项研究使用成本效果分析，2 项研究同时使用成本效用分析和成本效果分析，1 项研究使用成本后果分析，1 项研究使用成本效益分析，8 项研究使用成本最小化分析。